Publicaciones (17) Publicaciones de RAQUEL PÉREZ ROBLES

2024

  1. Improved sample introduction approach in hydrophilic interaction liquid chromatography to avoid breakthrough of proteins

    Journal of Chromatography A, Vol. 1713

2023

  1. Analysing the In-Use Stability of mRNA-LNP COVID-19 Vaccines Comirnaty™ (Pfizer) and Spikevax™ (Moderna): A Comparative Study of the Particulate

    Vaccines, Vol. 11, Núm. 11

  2. Comprehensive physicochemical characterization of a peptide-based medicine: Teduglutide (Revestive®) structural description and stress testing

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 184, pp. 103-115

  3. Practical study on the impact of injection conditions in gradient elution mode for the analysis of therapeutic proteins when using very short columns

    Journal of Chromatography A, Vol. 1709

2022

  1. Combined use of UV and MS data for ICH Stability-Indication Method: Quantification and isoforms identification of intact nivolumab

    Microchemical Journal, Vol. 182

  2. Degradation and in-use stability study of five marketed therapeutic monoclonal antibodies by generic weak cation exchange liquid chromatographic method ((WCX)HPLC/DAD)

    Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, Vol. 1203

  3. Method for identification and quantification of intact teduglutide peptide using (RP)UHPLC-UV-(HESI/ORBITRAP)MS

    Analytical Methods, Vol. 14, Núm. 43, pp. 4359-4369

  4. Tracking the physicochemical stability of teduglutide (Revestive®) clinical solutions over time in different storage containers

    Journal of Pharmaceutical and Biomedical Analysis, Vol. 221

2021

  1. Stability study over time of clinical solutions of ziv-aflibercept prepared in infusion bags using a proper combination of physicochemical and functional strategies

    Journal of Pharmaceutical and Biomedical Analysis, Vol. 203

2020

  1. Comparing different domains of analysis for the characterisation of N-glycans on monoclonal antibodies

    Journal of Pharmaceutical Analysis, Vol. 10, Núm. 1, pp. 23-34

  2. Comprehensive biophysical and functional study of ziv-aflibercept: characterization and forced degradation

    Scientific Reports, Vol. 10, Núm. 1

  3. Control de calidad sensorial del jamóncurado. Metodología para la formacióny cualificación del panel de cata y parala validación del método de cata

    Eurocarne: La revista internacional del sector cárnico, Núm. 286, pp. 68-78

  4. Intact charge variant analysis of ziv-aflibercept by cationic exchange liquid chromatography as a proof of concept: Comparison between volatile and non-volatile salts in the mobile phase

    Journal of Pharmaceutical and Biomedical Analysis, Vol. 185

  5. Use of subcutaneous tocilizumab to prepare intravenous solutions for COVID-19 emergency shortage: Comparative analytical study of physicochemical quality attributes

    Journal of Pharmaceutical Analysis, Vol. 10, Núm. 6, pp. 532-545

2019

  1. Comparative Stability Studies of Different Infliximab and Biosimilar CT-P13 Clinical Solutions by Combined Use of Physicochemical Analytical Techniques and Enzyme-Linked Immunosorbent Assay (ELISA)

    BioDrugs, Vol. 33, Núm. 2, pp. 193-205

2018

  1. Development and validation of a (RP)UHPLC-UV-(HESI/Orbitrap)MS method for the identification and quantification of mixtures of intact therapeutical monoclonal antibodies using a monolithic column

    Journal of Pharmaceutical and Biomedical Analysis, Vol. 159, pp. 437-448

2017

  1. Method for the comparison of complex matrix assisted laser desorption ionization-time of flight mass spectra. Stability of therapeutical monoclonal antibodies

    Chemometrics and Intelligent Laboratory Systems, Vol. 170, pp. 58-67